HealthEquity Inc.

NAS: HQY

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
HealthEquity Inc.

Before the Bell

 --Quotes are delayed by 20 min

Jun 8, 2023, 7:42 a.m.

HQY
/zigman2/quotes/210521638/composite

$

65.07

Change

-0.31 -0.47%

Volume

Volume 1

Quotes are delayed by 20 min

/zigman2/quotes/210521638/composite

Previous close

$ 65.38

$ 65.38

Change

-0.29 -0.44%

Day low

Day high

$64.74

$66.94

Open

52 week low

52 week high

$48.86

$79.20

Open

Company Description

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Valuation

Price to Sales Ratio

5.96

Price to Book Ratio

2.72

Price to Cash Flow Ratio

32.55

Enterprise Value to EBITDA

28.81

Enterprise Value to Sales

6.36

Efficiency

Total Asset Turnover

0.28

Liquidity

Current Ratio

2.92

Quick Ratio

2.92

Cash Ratio

1.94

Profitability

Gross Margin

45.90

Operating Margin

4.37

Pretax Margin

-4.42

Net Margin

-3.03

Return on Assets

-0.84

Return on Equity

-1.39

Return on Total Capital

1.31

Capital Structure

Total Debt to Total Assets

32.20

Officers and Executives

Name Age Officer Since Title
Mr. Jon Kessler 52 2009 Executive Chairman
Ms. Angelique Hill 51 2018 Executive Vice President-Operations
Mr. Tyson Murdock 48 2018 Senior Vice President & Controller
Mr. Elimelech Rosner 64 2022 Chief Technology Officer & Executive VP
Ms. Jody Dietel - 2019 Senior Vice President-Compliance & Regulatory News

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/04/2023 Stephen D. Neeleman
FOUNDER AND VICE CHAIRMAN; Director 		1,886   Derivative/Non-derivative trans. at $55.99 per share. 105,597
04/04/2023 Elimelech Rosner
EVP, CHIEF TECHNOLOGY OFFICER 		4,715   Derivative/Non-derivative trans. at $55.99 per share. 263,992
04/04/2023 Tyson Murdock
EVP & CFO 		3,017   Derivative/Non-derivative trans. at $55.99 per share. 168,921
04/04/2023 Delano Ladd
EVP, GC & CORPORATE SECRETARY 		1,189   Derivative/Non-derivative trans. at $55.99 per share. 66,572
04/04/2023 Larry Trittschuh
EVP CHIEF SECURITY OFFICER 		1,512   Derivative/Non-derivative trans. at $55.99 per share. 84,656
04/03/2023 Stephen D. Neeleman
FOUNDER AND VICE CHAIRMAN; Director 		4,429   Derivative/Non-derivative trans. at $57.7 per share. 255,553
04/03/2023 Jon Kessler
PRESIDENT AND CEO; Director 		40,309   Derivative/Non-derivative trans. at $57.7 per share. 2,325,829
04/03/2023 Tyson Murdock
EVP & CFO 		2,768   Derivative/Non-derivative trans. at $57.7 per share. 159,713
04/03/2023 Delano Ladd
EVP, GC & CORPORATE SECRETARY 		3,472   Derivative/Non-derivative trans. at $57.7 per share. 200,334
04/03/2023 Larry Trittschuh
EVP CHIEF SECURITY OFFICER 		3,438   Derivative/Non-derivative trans. at $57.7 per share. 198,372
03/29/2023 Stephen D. Neeleman
FOUNDER AND VICE CHAIRMAN; Director 		13,057   Award at $0 per share. 0
03/29/2023 Stephen D. Neeleman
FOUNDER AND VICE CHAIRMAN; Director 		15,006   Award at $0 per share. 0
03/29/2023 Jon Kessler
PRESIDENT AND CEO; Director 		86,179   Award at $0 per share. 0
03/29/2023 Elimelech Rosner
EVP, CHIEF TECHNOLOGY OFFICER 		25,725   Award at $0 per share. 0
03/29/2023 Tyson Murdock
EVP & CFO 		7,261   Award at $0 per share. 0
03/29/2023 Tyson Murdock
EVP & CFO 		23,581   Award at $0 per share. 0
03/29/2023 Delano Ladd
EVP, GC & CORPORATE SECRETARY 		10,446   Award at $0 per share. 0
03/29/2023 Delano Ladd
EVP, GC & CORPORATE SECRETARY 		12,862   Award at $0 per share. 0
03/29/2023 Larry Trittschuh
EVP CHIEF SECURITY OFFICER 		9,442   Award at $0 per share. 0
03/29/2023 Larry Trittschuh
EVP CHIEF SECURITY OFFICER 		15,006   Award at $0 per share. 0
03/28/2023 Tyson Murdock
EVP & CFO 		557   Derivative/Non-derivative trans. at $57.27 per share. 31,899
03/28/2023 Delano Ladd
EVP, GC & CORPORATE SECRETARY 		345   Derivative/Non-derivative trans. at $57.27 per share. 19,758
03/28/2023 Larry Trittschuh
EVP CHIEF SECURITY OFFICER 		100   Derivative/Non-derivative trans. at $57.27 per share. 5,727
02/01/2023 Ian R. Sacks
Director 		1,060   Award at $0 per share. 0
02/01/2023 Stuart Blain Parker
Director 		1,102   Award at $0 per share. 0
02/01/2023 Rajesh Natarajan
Director 		1,229   Award at $0 per share. 0
02/01/2023 Paul M. Black
Director 		1,229   Award at $0 per share. 0
12/27/2022 Stephen D. Neeleman
FOUNDER AND VICE CHAIRMAN; Director 		2,000   Gift at $0 per share. 0
12/19/2022 Larry Trittschuh
EVP CHIEF SECURITY OFFICER 		770   Derivative/Non-derivative trans. at $60.71 per share. 46,746
12/14/2022 Gayle Wellborn
Director 		5,237   Disposition at $62 per share. 324,694
10/21/2022 Delano Ladd
EVP, GC & CORPORATE SECRETARY 		5,897   Disposition at $75 per share. 442,275
10/18/2022 Ian R. Sacks
Director 		18,000   Gift at $0 per share. 0
/news/latest/company/us/hqy

MarketWatch News on HQY

  1. HealthEquity stock price target raised to $85 from $75 at Raymond James

    9:01 a.m. Dec. 12, 2022

    - Emily Bary

  2. HealthEquity price target raised to $94 from $89 at Guggenheim

    7:46 a.m. Dec. 7, 2022

    - Emily Bary

  3. HealthEquity stock price target raised to $85 from $76 at BofA Securities

    9:56 a.m. Sept. 22, 2022

    - Tomi Kilgore

  4. HealthEquity price target lifted to $75 from $70 at Raymond James

    7:31 a.m. Sept. 12, 2022

    - Emily Bary

  5. HealthEquity stock price target raised to $62 from $52 at Deutsche Bank

    9:06 a.m. Feb. 24, 2022

    - Tomi Kilgore

  8. HealthEquity downgraded to outperform from strong buy at Raymond James

    9:03 a.m. Dec. 7, 2021

    - Tomi Kilgore

  9. HealthEquity stock price target cut to $75 from $92 at Deutsche Bank

    7:15 a.m. Sept. 21, 2021

    - Tomi Kilgore

  10. HealthEquity stock price target raised to $72 from $61 at J.P. Morgan

    8:16 a.m. Dec. 8, 2020

    - Tomi Kilgore

  11. HealthEquity downgraded to sector weight from overweight at KeyBanc Capital

    6:58 a.m. Dec. 2, 2020

    - Tomi Kilgore

  12. HealthEquity stock price target cut to $75 from $90 at Raymond James

    7:57 a.m. April 8, 2020

    - Tomi Kilgore

  13. HealthEquity price target upped to $68 from $55 at SunTrust

    7:26 a.m. March 26, 2020

    - Emily Bary

  15. HealthEquity stock price target cut to $65 from $86 at KeyBanc Capital

    6:18 a.m. March 17, 2020

    - Tomi Kilgore

  16. Small-Cap ‘Darlings’ Are Perking Up in 2020

    11:47 a.m. Jan. 21, 2020

    - Barron's Online

  17. Here’s how Wall Street’s favorite stock picks turned out in 2019

    10:48 a.m. Dec. 21, 2019

    - Philip van Doorn

  18. HealthEquity stock price target raised to $77 from $70 at KeyBanc Capital

    9:09 a.m. Dec. 4, 2019

    - Tomi Kilgore

  19. Funds’ Most Loved – and Hated – Small-Cap Stocks

    9:04 a.m. Sept. 17, 2019

    - Barron's Online

  20. HealthEquity stock price target cut to $76 from $98 at Oppenheimer

    7:57 a.m. Sept. 4, 2019

    - Tomi Kilgore

  21. Loading more headlines...
/news/nonmarketwatch/company/us/hqy

Other News on HQY

  1. 10-K: HEALTHEQUITY, INC.

    4:15 p.m. March 30, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. AMUSSEN HUNSAKER ASSOCIATES LLC Buys 2, Sells 3 in 4th Quarter

    11:00 a.m. Feb. 8, 2023

    - GuruFocus.com

  5. 10-Q: HEALTHEQUITY, INC.

    5:05 p.m. Dec. 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. PINC vs. HQY: Which Stock Is the Better Value Option?

    12:40 p.m. Nov. 21, 2022

    - Zacks.com

  11. PINC or HQY: Which Is the Better Value Stock Right Now?

    11:40 a.m. Nov. 3, 2022

    - Zacks.com

  14. PINC vs. HQY: Which Stock Is the Better Value Option?

    11:40 a.m. Oct. 18, 2022

    - Zacks.com

  16. How to Reap Tax Breaks From Your HSA

    4:06 a.m. Oct. 19, 2022

    - The Wall Street Journal Interactive Edition

At a Glance

HealthEquity, Inc.

15 West Scenic Pointe Drive

Suite 100

Draper, Utah 84020

Phone

1 8017271000

Industry

Software

Sector

Technology

Fiscal Year-end

01/2024

View SEC Filings

Revenue

$861.75M

Net Income

$-26.14M

Employees

3,208

Annual Report for HQY

/news/pressrelease/company/us/hqy

Press Releases on HQY

  8. HealthEquity Reports Record HSA Sales, Asset Growth

    5:02 p.m. Feb. 14, 2023

    - GlobeNewswire

  13. HealthEquity Sets Date to Announce Third Quarter Results

    5:01 p.m. Nov. 15, 2022

    - GlobeNewswire

  17. HealthEquity Expands Board of Directors

    4:01 p.m. Sept. 1, 2022

    - GlobeNewswire

  19. HealthEquity Recognized as Top Workplace in Arizona

    3:06 p.m. Aug. 8, 2022

    - GlobeNewswire

Link to MarketWatch's Slice.